Visilizumab
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Visilizumab, covering 2008-08-05 to 2014-07-04. Get the full timeline:
Most recent: Clinical Trial Update: Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation [Phase 2]